MedPath

Clinical study on effect of different duration of moxibustion on quality of life in patients with rheumatoid arthritis of cold-dampness obstructin type

Not Applicable
Recruiting
Conditions
Rheumatoid arthritis of cold-dampness obstructin type
Registration Number
ITMCTR2100004278
Lead Sponsor
Hubei Provincial Hospital of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients met the diagnostic criteria of rheumatoid arthritis of cold dampness obstruction type;
2. Patients aged 18-60 years;
3. Patients with definite joint pain;
4. Those who have not used glucocorticoids or muscle relaxants in the past week, or those who have taken the above drugs in a short period (3-5 days) and stopped using them for more than 7 days;
5. Patients who have not received acupuncture and moxibustion treatment within one week;
6. Those patients who had informed consent to this study and voluntarily participated in the follow-up.
Note: patients who meet the above 6 items can be included in this study.

Exclusion Criteria

1. Advanced patients with severe joint deformity, grade IV joint function, ankylosing spondylitis, psoriatic arthritis, gouty arthritis and systemic lupus erythematosus;
2. Patients with blood, liver, cardiovascular disease, diabetes or other severe joint symptoms, such as joint swelling, hot pain, local flush on body surface, body surface damage, burning, etc.;
3. Patients with respiratory diseases and allergic to moxibustion and ginger;
4. Pregnant or lactating women;
5. The patients with mental illness can not cooperate with the treatment;
6. Patients with previous history of tumor and tuberculosis.
Note: any one of the above six items can not be included in this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
C-reactive protein;erythrocyte sedimentation rate;Effect evaluation;Quality of life;Symptom and sign rating scale;
Secondary Outcome Measures
NameTimeMethod
urine routine;blood routine;
© Copyright 2025. All Rights Reserved by MedPath